Registro completo de metadatos
| Campo DC | Valor | Lengua/Idioma |
|---|---|---|
| dc.contributor.advisor | Gil-Bazo, I. (Ignacio) | - |
| dc.creator | Baraibar-Argota, I. (Iosune) | - |
| dc.date.accessioned | 2021-07-08T07:21:51Z | - |
| dc.date.available | 2021-07-08T07:21:51Z | - |
| dc.date.issued | 2021-06-08 | - |
| dc.date.submitted | 2021-06-22 | - |
| dc.identifier.citation | BARAIBAR ARGOTA, Iosune. “Novel therapeutic strategy to prevent immune escape in metastatic NSCLC through combined PD-1 and Id1 blockade". Gil, I. (dirs.). Tesis doctoral. Universidad de Navarra, Pamplona, 2021. | es_ES |
| dc.identifier.uri | https://hdl.handle.net/10171/61070 | - |
| dc.description.abstract | According to the Global Cancer Observatory (http://gco.iarc.fr), primary lung cancer ranks as the most common tumor worldwide and the leading cause of cancer-related mortality. In 2020, 2.2 million new lung cancer cases were diagnosed, which comprises 12.2% of total cancers. | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Universidad de Navarra | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | es_ES |
| dc.subject | Materias Investigacion::Ciencias de la Salud::Oncología | es_ES |
| dc.subject | Cáncer de pulmón | es_ES |
| dc.subject | Lung cancer | es_ES |
| dc.title | Novel therapeutic strategy to prevent immune escape in metastatic NSCLC through combined PD-1 and Id1 blockade | es_ES |
| dc.type | info:eu-repo/semantics/doctoralThesis | es_ES |
Ficheros en este ítem:
Estadísticas e impacto
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.
